Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Agency for Care Effectiveness
Withdrawn

Tofacitinib, ustekinumab and vedolizumab for treating inflammatory bowel disease

6 February 2026

Condition

Gastrointestinal tract

Published on 01 Jul 2022
Last Updated on 06 Feb 2026


Tofacitinib, ustekinumab and vedolizumab for treating inflammatory bowel disease Guidance is outdated and has been withdrawn on 1 February 2026.

Tofacitinib, ustekinumab and vedolizumab for treating inflammatory bowel disease (Withdrawn 6 Feb 2026) [PDF, 131 KB] (opens in new tab)

PES Treatments for ulcerative colitis and Crohn’s disease (Withdrawn 6 Feb 2026) [PDF, 188 KB] (opens in new tab)